NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: HCG · data 2026-10-31
HealthCare Global Enterprises Ltd.
In plain words
Price: 24.4% below its 52-week high of ₹775.
Delivery: 58.6% of traded shares were kept for delivery over the last 10 sessions, against 56.6% over the last 60.
Latest results: a net profit of ₹7 cr for the quarter ended Mar 2025.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹2,620 cr |
| Net profit (last 12 months) | ₹23 cr |
| Sales growth, 3 years (yearly) | 14.5% |
| Profit growth, 3 years (yearly) | -22.3% |
At a glance
Promoters 62.5%, pledged 5.7%, institutions 15.4%.
P/E 375.2, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 1.2%, ROCE 8.3%, operating margin 8.3%: how much profit it earns on the money it uses.
Debt/equity 1.30, Profit growth -22.3% and sales growth 14.5% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (1.2%).
- Profit fell 22.3% a year over 3 years.
- Promoters have pledged 5.7% of their shares.
- Expensive on earnings (P/E 375.2).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q4 FY25)
HCG Q4 FY25 results (consolidated figures, as filed on NSE).
Revenue was ₹585.16 crore.
Net profit was ₹7.36 crore.
Operating margin was 18.1%.
EPS was ₹0.53.
HCG के Q4 FY25 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹585.16 करोड़।
शुद्ध मुनाफ़ा: ₹7.36 करोड़।
ऑपरेटिंग मार्जिन: 18.1%।
EPS: ₹0.53।
HCGના Q4 FY25 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹585.16 કરોડ.
ચોખ્ખો નફો: ₹7.36 કરોડ.
ઓપરેટિંગ માર્જિન: 18.1%.
EPS: ₹0.53.
Written from the filed numbers. Not a recommendation.
Smart-money activity
18/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 6/30: Delivery 60.2% over the last 20 sessions vs 59.3% in the 40 before (1.02x); shares delivered per day 0.98x usual; 2 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 3 schemes hold it, about ₹374 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Rights ● Results
- 2 Mar 26Rights Rights issue 1:17 · premium ₹502 (ex-date) -3.8% next session
- 24 May 25Results Q4 FY25 results: net profit ₹7.4 cr -5.8% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Mar 2025 | ₹585 cr | ₹7 cr | — | 18.1% | 0.53 |
Shareholding trend
| Holder | Jun 2025 | Dec 2024 |
|---|---|---|
| Promoters | 62.46% | 71.23% |
| Foreign institutions (FII) | 2.16% | 2.77% |
| Domestic institutions (DII) | 13.22% | 12.94% |
| Mutual funds | 9.43% | 10.04% |
| Retail investors | 6.37% | 5.05% |
| Number of shareholders | 47,028 | 32,820 |
Common questions
What was HealthCare Global Enterprises Ltd.'s latest quarterly profit?
HealthCare Global Enterprises Ltd. reported a net profit of ₹7 cr for the quarter ended Mar 2025, on revenue of ₹585 cr.
How much do promoters hold in HealthCare Global Enterprises Ltd.?
Promoters held 62.46% of HealthCare Global Enterprises Ltd. at the end of Jun 2025, with 5.70% of promoter shares pledged.
Is HealthCare Global Enterprises Ltd. debt-free?
Its latest reported debt-to-equity ratio is 1.3, meaning borrowings are larger than shareholders' equity.
What is HealthCare Global Enterprises Ltd.'s P/E ratio?
About 375.2, based on the last 12 months' earnings and a price of ₹585.55 (data 2026-10-31).
What is the 52-week high and low of HealthCare Global Enterprises Ltd.?
The 52-week high is ₹775 and the 52-week low is ₹513.3.
Mutual funds holding HealthCare Global Enterprises Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 3 schemes holding about ₹374 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Nippon India ELSS Tax Saver Fund | Nippon India Mutual Fund | 1.75% | ₹247 cr |
| SBI Healthcare Opportunities Fund | SBI Mutual Fund | 1.70% | ₹100 cr |
| NIPPON INDIA RETIREMENT FUND - WEALTH CREATION SCHEME | Nippon India Mutual Fund | 0.94% | ₹28 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| HealthCare Global Enterprises Ltd. | ₹585.55 | ₹8,731 cr | 375.2 | — | 1.2% | 8.3% | 1.3 | -22.8% |
| Park Medi World Limited | ₹219.7 | ₹9,513 cr | — | — | 16.7% | 20.2% | 0.18 | +38.4% |
| Yatharth Hospital and Trauma Care Services Limited | ₹926.9 | ₹8,942 cr | 49.3 | — | 10.4% | 11.6% | 0.15 | +16.3% |
| Jupiter Life Line Hospitals Ltd. | ₹257.15 | ₹8,402 cr | 45.2 | 5.2 | 13.4% | 13.2% | 0.38 | -17.5% |
| Paras Healthcare Limited | ₹740.6 | ₹7,963 cr | — | 18.9 | 13% | 13.8% | 3.53 | +2.9% |
| Kovai Medical Center & Hospital Ltd. | ₹5,816 | ₹6,356 cr | 25.2 | — | 20.3% | 20.6% | 0.31 | +131.5% |
Compare HCG with PARKHOSPS in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open HCG in NSE Scanner →